Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

Pyrosequencing as a Fast and Reliable Method in Detecting the MYD88 p.L265P Mutation in Decalcified Formalin-Fixed and Paraffin-Embedded Tissues

  • Gebauer, Niklas (Department of Pathology, Reference Centre for Lymph Node Pathology and Hematopathology, University Hospital of Schleswig-Holstein) ;
  • Bernard, Veronica (Department of Pathology, Reference Centre for Lymph Node Pathology and Hematopathology, University Hospital of Schleswig-Holstein) ;
  • Roohner, Claudia (Department of Pathology, Reference Centre for Lymph Node Pathology and Hematopathology, University Hospital of Schleswig-Holstein) ;
  • Krokowski, Manuela (Department of Pathology, Reference Centre for Lymph Node Pathology and Hematopathology, University Hospital of Schleswig-Holstein) ;
  • Merz, Hartmut (Department of Pathology, Reference Centre for Lymph Node Pathology and Hematopathology, University Hospital of Schleswig-Holstein) ;
  • Feller, Alfred C. (Department of Pathology, Reference Centre for Lymph Node Pathology and Hematopathology, University Hospital of Schleswig-Holstein) ;
  • Thorns, Christoph (Department of Pathology, Reference Centre for Lymph Node Pathology and Hematopathology, University Hospital of Schleswig-Holstein)
  • Received : 2013.08.12
  • Accepted : 2013.12.17
  • Published : 2014.03.02
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 2011; 470:115-9. https://doi.org/10.1038/nature09671
  2. Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, et al. MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia. N Engl J Med 2012;367:826-33. https://doi.org/10.1056/NEJMoa1200710
  3. Xu L, Hunter ZR, Yang G, Zhou Y, Cao Y, Liu X, et al. MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Blood 2013;121:2051-8. https://doi.org/10.1182/blood-2012-09-454355
  4. Poulain S, Roumier C, Decambron A, Renneville A, Herbaux C, Bertrand E, et al. MYD88 L265P mutation in Waldenstrom macroglobulinemia. Blood 2013;121:4504-11. https://doi.org/10.1182/blood-2012-06-436329
  5. Loiarro M, Ruggiero V, Sette C. Targeting the Toll-like receptor/interleukin 1 receptor pathway in human diseases: rational design of MYD88 inhibitors. Clin Lymphoma Myeloma Leuk 2013;13:222-6. https://doi.org/10.1016/j.clml.2013.02.003
  6. Wang CZ, Lin J, Qian J, Shao R, Xue D, Qian W, et al. Development of high-resolution melting analysis for the detection of the MYD88 L265P mutation. Clin Biochem 2013;46:385-7. https://doi.org/10.1016/j.clinbiochem.2012.11.007
  7. Bock O, Neuse J, Hussein K, Brakensiek K, Buesche G, Buhr T, et al. Aberrant collagenase expression in chronic idiopathic myelofibrosis is related to the stage of disease but not to the JAK2 mutation status. Am J Pathol 2006;169:471-81. https://doi.org/10.2353/ajpath.2006.060110